Ocugen, Inc. — Director's Dealing 2023

Feb 17, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2023-01-03

Reporting Person: Upadhyay Arun (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-01-03	Common Stock	F	7102	$1.25	Disposed	392981	Direct

Footnotes

F1: This Form 4 is being filed late due to an administrative error.